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Antiacanthain and granulosain are the partially purified proteolytic extracts from
the South American native fruits of Bromelia antiacantha (Bertol. ) and Solanum
granuloso leprosum, respectively. The aim of this work was to compare the ability
of both soluble and immobilized antiacanthain and granulosain for the synthesis of
Z-Tyr-Val-OH, a novel antibacterial dipeptide, in different reaction systems formed
by almost anhydrous organic solvents (Xw: 1 × 10
−5) and several percentages of
immiscible organic solvents in 100mM Tris(hydroxymethyl)aminomethane hydrochloride
buffer pH 8.0. Soluble antiacanthain in half of the 24 different organic biphasic media
showed higher catalytic potential than in 100mM Tris(hydroxymethyl)aminomethane
hydrolchloride buffer pH 8.0. Soluble granulosain showed lower catalytic potential
in all liquid-liquid biphasic media than in the same buffer. However, 50% (v/v) ethyl
ethanoate in 100mM Tris(hydroxymethyl)aminomethane hydrolchloride buffer pH 8.0
allowed to express the highest catalytic potential of both soluble enzymes. In 50%
v/v ethyl ethanoate, soluble antiacanthain and granulosain catalyzed the synthesis of
Z-Tyr-Val-OH with 72 ± 0.15 and 60 ± 0.10% maximal peptide yields, respectively.
Multi-point immobilization in glyoxyl-silica did not lead to better peptide yields than
soluble enzymes, in that liquid-liquid biphasic medium under the same reaction
conditions. Soluble and glyoxyl-silica immobilized antiacanthain in almost anhydrous
ethyl ethanoate (Xw: 1 × 10
−5) were able to retain 17.3 and 45% of the initial
proteolytic activity of antiacanthain in 100mM Tris hydrolchloride buffer pH 8.0,
respectively, at 40◦C under agitation (200 rpm). Soluble and glyoxyl-silica immobilized
granulosain were inactivated under the same reaction conditions. Glyoxyl-silica
immobilized antiacanthain showed to be a robust biocatalyst in almost anhydrous
ethyl ethanoate (Xw: 1 × 10
−5), eliciting the best peptide yield (75 ± 0.13%). The
synthesis reaction of Z-Tyr-Val-OH could not proceed when soluble antiacanthain
was used under the same conditions. Both peptidases only catalyzed the synthesis
reaction under kinetic control, using activated acyl donor substrates. Finally, this
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work reports a novel broad-spectrum antibacterial peptide that significantly decreased (p
≤ 0.05) the specific growth rates of Gram positive and Gram negative microorganisms at
very low concentrations (≥15 and 35µg/ml, respectively); contributing with a new safe
food preservative of applying for different food systems.
Keywords: novel antibacterial peptide, safe food preservative, peptide enzymatic synthesis, antiacanthain,
granulosain, multi-point immobilization in glyoxyl-silice
INTRODUCTION
The demand for fresh food, easy to prepare, and ready for
consumption, represents a challenge for food quality and safety.
Food products can suffer undesirable microbial contamination
that alter their sensory, physical-chemical and nutritional
properties, causing their deterioration and significant economic
losses. Furthermore, some microorganisms can cause foodborne
illness (1, 2).
The growing consumer awareness of the potential negative
impact of synthetic antibiotics on health has prompted the search
for alternative more natural preservatives that can improve food
safety and quality. Thus, several emerging biotechnologies based
on bacteriophages and endolysins, inhibitors, and antagonists
of bacterial quorum sensing, and antimicrobial agents from
natural sources were actively researched (3–6). However,
these technologies have shown several limitations such as
low solubility, cytotoxicity, instability, undesirable flavors, and
interactions with food components (2, 7).
In the last decades, an intense research on antimicrobial
peptides (AMPs) has been reported in the literature, but only
Nisin (of bacterial origin) and Lysozyme (of animal origin), called
E234 and E1105 on the JECFA list of food additives, respectively;
are so far the only peptides approved for commercialization by
the World Health Organization (8).
The use of AMPs as food preservatives has attracted attention
because they are considered as a promising and safe option in
the face of the dramatic increase of microorganisms which are
not only resistant to antibiotics but also are more tolerant of food
processing and preservation methods (9, 10).
AMPs are quite ubiquitous conserved molecules present in all
kind of organisms from prokaryotes to humans (11). In higher
organisms, AMPs are components of the innate immune system
(host-defense peptides) and so, beyond their direct antimicrobial
activity, they are endowed with immune-modulatory properties
(12). In insects and plants, AMPs act as protectants against
microbial pathogens (13), while in bacteria, AMPs are used as
weapons for gaining ecological niches (14). AMPs have acquired
significance as new anti-infective compounds because of the
rapidly increasing resistance to conventional antibiotics, so they
are becoming a promising alternative to them (15). In fact, AMPs
display a wide spectrum of antimicrobial activities including
Gram positive and Gram negative bacteria (16), fungi (17)
and viruses as targets (18), having low propensity for eliciting
resistance (19, 20).
Nowadays, different technologies are available for the
production of peptides: extraction from natural sources (20),
recombinant DNA technology (21), production in transgenic
animals and plants (22, 23) and in cell-free expression systems
(24), fermentation (25), chemical synthesis (26), and enzymatic
synthesis, using proteases as catalysts (27). Enzymatic synthesis
of peptides using proteases offers several advantages, such as high
activity, specificity and selectivity of the catalyst under moderate
reaction conditions. This is usually a more economical and
environmentally friendly technology than chemical processes
(27). Nonetheless, some plant peptidases have been investigated
as catalysts for the enzymatic synthesis of peptides (11).
Particularly, the peptidases from fruits of Bromelia antiacantha
(Bertol.) and Solanum granuloso leprosum, referred to as
antiacanthain and granulosain, respectively, have not yet been
investigated in this respect (28–33).
Vallés et al. (30) informed on a new cysteine peptidase which
was purified from the B. antiacantha fruits, and it was named
antiacanthain A. The partially purified fraction exhibited good
specific activity from pH 5.0 to 8.0, being the highest value at pH
6.0, as well as a noticeable stability between 37and 40◦C, during
3 h (30).
Vallés et al. (32) also reported on another cysteine peptidase
from the S. granuloso-leprosum fruit; which was named
granulosain I. The partially purified peptidase exhibited maximal
specific activities from pH 5.2 to 8.0, and temperatures from 40
to 50◦C (33).
Enzyme purification techniques show some restrictions
related to the scaling up and increasing production costs to
be applied to industrial process (34). Consequently, partially
purified extracts were selected for this study.
Enzymatic synthesis of peptides cannot progress in aqueous
solutions because the hydrolysis activity of proteases prevails
over their synthesis activity. The selection of the most suitable
reaction media as well as the best design and arrangement of
the biocatalyst are the main requirements to achieve a successful
enzymatic peptide synthesis, since the natural environment
of proteases is quite different from the aggressive conditions
imposed by the organic solvents (11).
The immobilization of enzymes in a certain support or
matrix shows several advantages over their soluble forms, such
as: greater stability of the enzyme, lower operational cost
and easier separation and recovery of the enzyme for reuse
(35). Furthermore, an adequate immobilization technique can
improve the enzyme activity, product selectivity and substrate
specificity, and reduce the enzyme inhibition by substrates or
products (36).
Enzyme immobilization methods based on the formation of
covalent bonds are the most widely used. The enzyme binding to
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the support usually involves the side chains of lysine (ǫ-amino
group), cysteine (thiol group) and aspartic and glutamic acids
(carboxylic group), imidazole and phenolic groups, which are
not essential for the catalytic activity. The main advantage of this
strategy is the stability of the bonds formed between the enzyme
and the matrix, preventing the enzyme from being released into
the medium (36).
The multipoint covalent immobilization of enzymes on
supports activated with epoxy groups can be a very useful
tool to stabilize industrial enzyme. Silica matrix has a tunable
surface comprising hydrophilic silanol groups and moderately
hydrophobic siloxane groups, which can bemodified by chemical
treatments with organic functional groups to achieve a robust
biocatalyst. Glyoxyl-silica is a monofunctional matrix that forms
multi-point covalent linkages with non-ionized primary amines
and lead to stable bonds after a final reduction step (37). An
original contribution of this paper is the immobilization of
antiacanthain and granulosain in a glyoxyl-silica support. As
far as is known, there are no other works reported on the
aforementioned immobilized enzymes or on their application to
peptide synthesis.
The aim of this work was to compare the ability of both soluble
and immobilized antiacanthain and granulosain for the synthesis
of N-α-carbobenzyloxy-L-Tyrosyl-L-Valine (Z-Tyr-Val-OH), a
novel antibacterial dipeptide, in different reaction systems
formed by almost anhydrous organic solvents (Xw: 1 × 10−5),
and several percentages (30, 50, and 70% v/v) of immiscible
organic solvents in 100mM Tris(hydroxymethyl)aminomethane




Octyltriethoxysilane (OTEOS, 97.5%), cetyltrimethylammonium
bromide (CTAB, ≥99%), N-α-benzoyl-DL-arginine-p-
nitroanilide (DL-BAPA, ≥96.0% high quality grade for HPLC),
monobasic sodium orthophosphate (p.a., anhydrous, ≥99.0%),
silicon dioxide (∼99%, 0.5–10µm), ethyl ethanoate (99%),
sodium tetrahydridoborate (99%), Tris(hydroxymethyl)amino
methane hydrochloride (≥99%), tetraethylammonium
chloride [BioUltra, for molecular biology (≥99% AT)],
L-Valine (Val-OH), Z-Tyr(Bzl)-OH (TLC, ≥98%), N-alpha-
carbobenzoxy-L-amino acid 4-nitrophenyl ester hydrochloride
(98%), 2-hydroxyethylmercaptan (≥99%), trifluoroethanoic acid
(≥99%), 4-nitroaniline (≥99.0%), 4-nitrophenol (≥99%), bovine
albumin (≥96%), and 1,2,3-propanetriol (99%) were bought
to Sigma-Aldrich (St. Louis, MO, USA). Sodium periodate
(≥99.5%), sodium trisilicate solution (≥99%), sodium hydrogen
carbonate (99.7%), L-cysteine hydrochloride hydrate (≥99%),
phosphate buffer (pH 7.2) and carbonate-bicarbonate buffer
(pH 10), diaminoethane-tetraacetic acid (90%), sulfuric acid
(99%), and sodium hydroxide solution (≥99%) were bought
to Merck KGaA (Darmstadt, Germany). Dimethyl sulfoxide
(for headspace gas chromatography SupraSolv R©), acetonitrile,
acetone, benzene, octanol, dichloromethane, diethyl ether,
cyclohexane, chlorobenzene, acetophenone, and ethyl ethanoate
(gradient grade for liquid chromatography LiChrosolv R©), formic
acid (98–100% for HPLC LiChropurTM) were also bought in
Merck KGaA (Darmstadt, Germany).
Plant Material
Samples of plant material were deposited in the Uruguayan
Botanical GardenMuseum “Prof. Atilio Lombardo,” which is part
of the Municipality of Montevideo, Uruguay. The samples of
these species were cataloged and inventoried by the Museum as
N◦ MVJB-23895 for Bromelia antiacantha and N◦ MVJB-9276
for Solanum granuloso-leprosum.
Preparation of Partially Purified Enzymatic
Extracts
Antiacanthain and granulosain, the partially purified proteolytic
extracts from the native ripe fruits of Bromelia antiacantha
(Bertol.) and Solanum granuloso leprosum, respectively, were
obtained according to Vallés et al. (31–33); and lyophilized for
later immobilization in glyoxyl-silica supports.
Electrophoresis
The molecular size (MW) of the proteins was determined by
denaturing and reducing electrophoresis in a TRICINE SDS-
PAGE differential buffer system, described by Schagger and Von
Jagow (38). Electrophoresis was carried out at constant voltage
(30V) until the samples reached the end of the concentrating gel.
The voltage was progressively increased every 10 s as the proteins
entered the spacer gel until reaching 100V, a value that was kept
constant until the end of the electrophoresis.
Protein Concentration and Enzyme
Specific Activity Assays
Proteins concentration was determined by Bradford protein
assay, with bovine albumin as protein standard (39). The
proteolytic specific activity of antiacanthain (0.075mg of
protein/ml) and granulosain (0.125mg of protein/ml) was
measured with DL-BAPA as substrate. Briefly, 0.5ml of partially
purified peptidase was incubated with 0.5ml of 5mM DL-BAPA
and 20mM L-cysteine in 100mM Tris(hydroxymethyl)amino
methane hydrochloride buffer pH 8 for 5min at 37◦C,
under agitation at 200 rpm. The absorbance of the reaction
product was measured using a spectrophotometer (UV-Vis
Spectrometer, Cintra 4040, GBC Scientific Equipment Ltd.,
Hampshire IL, USA) at λ: 410 nm. Product quantification
was performed using a standard curve of p-nitroaniline
in 100mM Tris(hydroxymethyl)aminomethane hydrochloride
buffer pH 8.0.
The enzymatic activity was expressed as international units
(IU). One IU was defined as the amount of peptidase
(antiacanthain or granulosain) that releases 1 µmol of p-
nitroaniline per min under the conditions mentioned above. As
a negative control, the activity assay was performed with buffer
solution instead of enzymatic extracts.
Stability of Proteolytic Enzymes
The stability of anticanthain and granulosain, in solution or
covalently linked to glyoxyl-silica support, was assayed under
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non-reactive conditions at 40◦C under agitation (200 rpm)
in: 100mM Tris(hydroxymethyl)amino methane hydrochloride
buffer pH 8, liquid-liquid biphasic systems constituted by 30,
50, and 70% v/v of hydrophobic organic dissolvent in 100mM
Tris(hydroxymethyl)amino methane hydrochloride buffer pH
8.0, and in almost anhydrous organic solvents (Xw: 1 × 10−5).
Immiscible organic solvents were selected from a design of
experiments carried out with 72 organic solvents, which clustered
them with respect to their physicochemical characteristics (40).
The residual activity (%) within a time range, which was
considered a sound criterion for enzyme replenishment, was
measured as detailed below. The catalytic potential of each
peptidase (CP) was evaluated from the area integration under the




A · dt (1)
Where, A is the expressed activity from initial to a final
replenishment time (tf) under stability conditions. CP is a
helpful descriptor for comparing the performances of several
biocatalysts, because it involves both the enzyme activity and
enzyme stability (41).
Determination of Water Content of the
Enzymes in Almost Anhydrous Organic
Solvents
The effect of different organic solvents on the stability of
antiacanthain and granulosain in almost anhydrous organic
solvents was studied at low and constant water content in the
enzymes. The amount of water on the enzyme after incubation
in each organic solvent with different concentration of water
was determined as follows: 0.4 g of lyophilized enzyme and 1ml
of each organic solvent with different degree of hydration were
suspended and incubated for 10min at 40◦C in a previously
weighted centrifuge tube. The suspension was centrifuged at
6,000 rpm (Refrigerated Centrifuge, Model 5430R Eppendorf,
Medical Equipment Specialists Inc., Ma, USA) for 5min and
the amount of water in the supernatant and in the pellet was
determined using a Karl Fisher Coulomb Titrator (model CA-
200, Mitsubishi).
Total amount of water in the pellet is the sum of water bound
to the enzyme and the amount of water into the organic solvent
trapped in the enzyme. Then, the net amount of water bound
to the enzyme was determined by subtracting the amount of
water bound to the trapped organic solvent to the amount of
water in the pellet. The amount of trapped organic solvent was
calculated on the basis of the weight of the entrapped organic
solvent (difference between the weight of the tube with the pellet
and the weight of the tube with the dry enzyme) and the amount
of water in the solvent (supernatant) (42).
The water content in the organic solvent and in the enzyme
was determined as volume percentage (% v/v) and weight
percentage (% w/w). The amount of water in the enzyme was
expressed as relative fraction of water (Xw), which is the ratio
between the molar concentration of water in the enzyme and the
molar concentration of pure water, and this value was set at Xw:
1× 10−5 (Equation 2).
Xw =
Concentration of water in the enzyme (M)
Pure total water concentration (55M)
(2)
Enzyme Preferences for Synthetic
Substrates
Preferences for peptidase substrates were evaluated as esterolytic
activity, using N-alpha-[(benzyloxy)carbonyl]-L-amino acid-p-
nitrophenyl esters as synthetic substrates (43). The trials
were carried out with 0.05ml of enzymatic solution, 2mM
diaminoethane-tetraacetic acid and 20mM L-cysteine, 0.1ml of
1M substrate (previously solubilized in dimethyl sulfoxide) and
0.85ml of 50% v/v ethyl ethanoate in 100mM diaminoethane-
tetraacetic acid buffer pH 8. The reactants were placed in a water
bath at 40◦C during 5min and the liberated 4-nitrophenol was
measured at λ: 405 nm. A calibration curve of 4-nitrophenol
allowed to evaluate the liberated p-nitrophenolate. Besides,
controls in absence of substrates or peptidases were performed.
One unit of esterolytic activity (UCBZ) was defined as the quantity
of protease necessary to liberate 1.0 µmol of 4-nitrophenol per
min under the described assay conditions.
Immobilization by Multi-Point Covalent
Binding of Anticanthain and Granulosain in
Glyoxyl-Silica
Initially, a reaction mixture containing the following
proportional composition was prepared: 1 SiO2: 0.30 Na2O:
0.24 hexadecyltrimethylammonium bromide (CTAB): 7.2 ethyl
ethanoate: 193 H2O. Then, for the synthesis of silica, 1.6 g CTAB
(4.4mm) was dissolved in 60ml of water (in order to obtain a
concentration of CTAB above its critical micelle concentration);
12.8ml ethyl ethanoate was added to the surfactant solution
and 4 g of sodium silicate (18mm) was dispersed by magnetic
stirring. The mixture was heated at 80◦C for 48 h without
stirring. The solid obtained was incinerated at 540◦C (heating
rate: 1.58◦C/min) in a muffle furnace (Thermo Scientific
Thermolyne FA48020-33, IL, USA) for 3 h. The synthesized
silica was chemically modified as follows: 1 g of silica (activated
under vacuum at 200◦C) was silylated at 94◦C in 30ml of 10%
v/v aqueous solution of glycidyl oxypropyl trimethoxysilane
(GPTMS) (pH 8.5), during 6 h under gentle agitation. The
hydrolysis of epoxy groups was carried out with H2SO4 (0.1M)
at 85◦C, during 2 h. After filtration, the support was washed with
water/acetone mixture (70:30) and dried. The oxidation was
carried out by contacting the support with 0.1M NaIO4 at 25◦C,
during 2 h. The concentration of glyoxyl groups was quantified
by back titration with NaHCO3/KI, using a spectrophotometer
(UV-Vis Spectrometer, Cintra 4040, GBC Scientific Equipment
Ltd., Hampshire IL, USA) at λ: 420 nm (44).
The support (0.309 g) was contacted with a solution of
antiacanthain or granulosain previously prepared in 0.1M
NaHCO3 buffer pH 10, at 25◦C, during 2 h, under stirring
at 200 rpm. 1ml of supernatant was taken for determining
enzyme activity. An immobilization control (soluble enzyme)
and a reagent control (without DL-BAPA) were also carried
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out. The biocatalyst was reduced using NaBH4 (1 mg/ml of
enzyme solution), during 15min at 4◦C, under agitation at 200
rpm. Finally, the support was washed with distilled water. The
immobilization yield in terms of activity (Ya) was calculated as
the percentage of the ratio between the offered activity (Ao)






Enzyme Synthesis of Z-Tyr-Val-OH
Dipeptide
The enzymatic synthesis of Z-Tyr-Val-OH was carried out
under kinetic and thermodynamic control, using solubilized,
and glyoxyl-silica immobilized peptidase (antiacanthain or
granulosain), in a liquid-liquid biphasic system (50% v/v
ethyl ethanoate in 100mM Tris(hydroxymethyl)amino methane
hydrochloride buffer pH 8) and in almost anhydrous organic
solvent (ethyl ethanoate, Xw: 1 × 10−5), at 40◦C under agitation
(200 rpm).
The selection of N-alpha-[(benzyloxy)carbonyl]-L-Tyr-p-
nitrophenyl ester (Z-Tyr-pNO) and L-valine (Val-OH), as acyl
donor and nucleophile substrates, respectively, was made from
the enzyme preference tests.
The amount of Z-Tyr-pNO was determined from its
maximum solubility in the immiscible organic dissolvent of
the liquid-liquid medium, the partition coefficient between
the phases, and the kinetic parameters (Km) of anticanthain
and granulosain.
The reaction of synthesis under kinetic control was carried
out in a liquid-liquid biphasic system, consisting of an
aqueous phase (100mM Tris(hydroxymethyl)aminomethane
hydrochloride buffer pH 8.0) containing 0.075 mg/ml of
soluble antiacanthain (1.875 IU/ml) or 0.125 mg/ml of soluble
granulosain (1.850 IU/ml), 20mM 2-mercaptoethanol, 7.55mM
of both Val-OH and triethyl ammonium (TEA), and an organic
phase (50% v/v ethyl ethanoate) containing 17.25mM of Z-Tyr-
pNO. The reaction was conducted at 40◦C in a GFL Shaking
Incubator Orbital Motion (Model 3031, Germany) at 200 rpm.
Aliquots (0.1ml) were taken from the aqueous and organic phase
at different times during 24 h and mixed with 0.1ml of 1% v/v
trifluoroacetic acid (TFA) for quenching the reaction. In addition,
the synthesis reaction under thermodynamic control was also
carried out using 17.25mM Z-Tyr-OH as acyl donor (instead of
Z-Tyr-pNO), under the same reaction conditions.
On the other hand, the synthesis of Z-Tyr-Val-OH under
kinetic and thermodynamic control was studied using the
peptidases suspended in almost anhydrous ethyl ethanoate (Xw: 1
× 10−5 in the enzyme), containing 17.25mM of Z-Tyr-pNO (or
Z-Tyr-OH), 20mM 2-mercaptoethanol, and 17.55mM of both
Val-OH and TEA.
In all the synthesis reactions described above, antiacanthain
(12.5 mg/ml) and granulosain (20.2 mg/ml) immobilized on
glyoxyl silica were used. Besides, the acyl acceptor concentration
was increased until its maximum solubility (75.5mM) in order to
maximize peptide yield (η).
Samples (100 µl) were periodically withdrawn during 48 h
from the reaction mixture supernatant, and 0.1ml of 1% v/v TFA
were added for quenching the reaction. The reaction components
were analyzed by RP-HPLC, and the synthesized peptide
was purified by chromatography, using a SPE-Cartridge C18
(RP18, ODS, Octadecyl, 3ml tube size, 500mg sorbent weight)
(Merck, Darmstadt, Germany), lyophilized and identified by
mass spectrometry (MS). At the same time, several blanks were
carried out using the protease only in the aqueous-organic
medium, each substrate separately and all reactants in absence
of enzyme.
Peptide yield (η) and conversion of acyl donor substrate (αs)









Where, So is the amount of acyl donor substrate at the initial time
of reaction, St is the amount of acyl donor substrate at a particular
time of reaction and P is the amount of synthetized peptide.
Analytical Control of Peptide Synthesis
RP-HPLC
Reactions were monitored by RP-HPLC (Gilson, Model 712,
Middleton, WI, USA) using a C18 column, 4.60 × 250mM
(Phenomenex, Torrance, CA, USA) and UV Detector at λ:
254 nm and 25◦C. The injection volume was 20 µl, the
flow rate of the mobile phase (50% v/v methyl cyanide in
Tris(hydroxymethyl)amino methane hydrochloride buffer pH 8)
was 800 µl/min. The product was purified by means of a C18
cartridge (Merck) (>95% purity) and dried in a concentrating
device (Thermo Scientific SavantTM SPD131DDA SpeedVac,
Madrid, España). The purified peptide was analyzed on a High-
performance liquid chromatography (Jasco, PW de Meern,
Nederland) equipped with a Photo Diode Array Detector, using
a XBridgeTM BEH C18 column (100 × 4.6mm, 3.5µm) (Waters
Corporation). The operating conditions were: injection volume
of 20 µl, flow rate of 1 ml/min, mobile phase formed by A: Mili
Q water with 2.5% fluoroacetic acid; and 30–100% gradient of B:
methyl cyanide with 2.5% fluoroacetic acid for 20 min).
Mass Spectrometry
The ESI-MS analysis of peptides was carried out with a Shimadzu
LC-MS 2020 (Montevideo, Uruguay), using 2 µg of peptide. The
mass spectrometer was optimized for 70–3000 m/z, with a 4.5
kV positive polarity, a 4500V capillary voltage, 8.0 psi nebulizer
gas, 5.0 L/min dry gas, heater interface temperature of 350◦C, for




The desalted peptides were mixed with a 1:1 (v/v) mixture
of α-cyano-4-hydroxy cinnamic acid (HCCA) saturated with a
solution comprising 30% methyl cyanide and 0.1% methanoic
acid, applied to a polished steel plate, and subjected to
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mass characterization by a Microflex R© MALDI-TOF mass
spectrometer (Bruker Daltonics, Bremen, Germany), which was
operated in positive ion mode and reflector detector, and
previously calibrated with an external standard (700–1800 Da).
The data were processed by means of the FlexControl Software
(Version 3.0, Bruker Daltonics GmbH).
Bacterial Strains
Eight Gram positive and Gram negative strains were assayed in
this work. Staphylococcus aureus ATCC 25923 and Escherichia
coli ATCC 25922 (American Type Culture Collection, Manassas,
VA, USA) were used as Gram positive and Gram negative
reference strains, respectively.
Besides, six wild strains isolated in the Central Microbiology
Laboratory of the San Luis Ministry of Health, Government of
San Luis, Province of San Luis, Argentina, were also used. They
were identified as:
• Staphylococcus aureus C00195 (Gram positive bacterium,
sensitive to commonly used antibiotics, such as methicillin,
penicillin, gentamicin, erythromycin, ciprofloxacin);
• Staphylococcus hominis A17771 (Gram positive bacterium,
sensitive to commonly used antibiotics, such as penicillin
and erythromycin);
• Enterococcus faecalis I00125 (Gram positive bacterium with
multidrug resistance to commonly used antibiotics, such as
vancomycin and β-lactam antibiotics);
• Escherichia coliA17683 (Gram negative bacterium, sensitive to
commonly used antibiotics).
• Klebsiella oxytoca A19438 (Gram negative bacterium with
natural or intrinsic resistance to ampicillin).
• Pseudomonas aeruginosa C00213 (Gram negative bacterium
resistant to carbapenem antibiotics).
Bacterial strains were grown for 24 h at 37◦C on Müller-
Hinton agar (Laboratorios Britania S.A., Buenos Aires,
Argentina) and they were maintained by successive peals.
Antibacterial Activity of Z-Tyr-Val-OH
The antibacterial activity of Z-Tyr-Val-OH against both Gram
positive and Gram negative bacteria was assayed by a kinetic-
turbidimetric method which was described by Talia et al. (46–
48). The cultures were aseptically transferred to 30ml of a
Müller-Hinton broth and incubated at 37◦C for 18 h with gentle
agitation, to be used as inoculum. The kinetic assays of microbial
growth were carried out in 10ml Erlenmeyer flasks with Müller-
Hinton broth containing 0.2ml of inoculum, without peptide
(control) and with increasing peptide concentrations (samples).
Erlenmeyer flasks were incubated in a GFL Shaking Incubator
Orbital Motion (Model 3031, Burgwedel, Germany) at 40◦C,
under agitation at 180 rpm. Aliquots were periodically withdrawn
at 20min intervals for 5 h and the transmittance (T) was
read at λ: 720 nm. The transmittance (T) was related to Nt
(Colony Forming Units (CFU)/ ml) in order to apply the
following equations:
lnNt Gram positive = 27.4− 10.3 · T (6)
lnNt Gram negative = 27.1− 8.56 · T (7)
Specific growth rates of bacteria were determined from
ln Nt vs. time plots. Minimum inhibitory concentrations
(MICs) of Z-Tyr-Val-OH against both Gram positive and
Gram negative bacteria were calculated from the plots of
specific growth rate vs. peptide concentration. MIC is defined
as the lowest concentration of an antimicrobial that will
inhibit the visible growth of a microorganism after overnight
incubation. The results obtained were compared with oxacillin
(a second generation penicillin antibiotic against moderate-
to-severe penicillinase-resistant staphylococcal infections), and
nalidixic acid (a synthetic naphthyridone antibiotic against Gram
negative bacteria such as E. coli) (46–48).
Data Statistical Analysis
Residual enzyme activity, activity yield (Ya), degree of conversion
of substrate (αs) and peptide yield (η) were calculated from
three separately assays which were performed in duplicate and
the results were informed as mean ± SD. The linear region of
the reaction progress of enzyme activity was also determined.
Antimicrobial activity was also obtained from three independent
trials which were done by duplicate, and data were reported
as mean ± SD. The Kruskal-Wallis method was used to test
the significant differences (p ≤ 0.05) between Z-Tyr-Val-OH
antimicrobial activity at different concentrations and the control
assay. The Kruskal-Wallis test was selected because it is a non-
parametric test that is applied to more than two independent
samples, with a reduced number of repetitions (N < 50) (49).
The data were processed by means of the IBM R© SPSS R© Statistics
V22.0 Software.
RESULTS AND DISCUSSION
Antiacanthain and Granulosain, Partially
Purified Peptidases From Native Fruits
Antiacanthain and granulosain, the partially purified proteolytic
extracts from the native ripe fruits of Bromelia antiacantha
(Bertol.) and Solanum granuloso leprosum, respectively, were
obtained using a low-cost purification method based on the
protein acetone precipitation (31–33).
The crude extracts of B. antiacantha and S. granuloso leprosum
fruits contain high concentrations of carbohydrates, pigments,
phenolic compounds, and vitamin C (50, 51). Furthermore,
these crude extracts contain several times more protein than
the partially purified extracts used in this work. As shown
in Figures 1A,B, a high purification degree of the main
protein fractions was achieved, corresponding to antiacantain
(23.335 kDa) and granulosain (23.878 kDa), respectively.
Both fractions showed high specific activity in 100mM Tris
(hydroxymethyl)amino methane hydrochloride buffer pH 8,
being 25 IU/mg of protein for antiacantain and 14.8 IU/mg of
protein for granulosain.
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FIGURE 1 | (A) Tricine SDS-PAGE. Lane 1: MW Maker See-blue (Invitrogen),
Lane 2: Bromelia antiacantha crude extract, Lane 3: Antiacanthain. (B) Tricine
SDS-PAGE. Lane 1: MW Protein marker V (Avantor), Lane 2: Solanum
granuloso-leprosum crude extract, Lane 3: Granulosain.
Immobilization by Multi-Point Covalent
Binding of Antiacanthain and Granulosain
in a Glyoxyl-Silica Carrier
In order to obtain robust biocatalysts able to withstand
the aggressive reaction conditions of the peptide synthesis,
antiacanthain, and granulosain were immobilized in glyoxyl-
silica carrier by means of multi-point covalent bonding. Silica
was the selected support material because it is one of the
most appropriate materials for forming multi-point Schiff base
bonds (52).
The offered activity of antiacanthain was 49 ± 0.01
IU/ml, equivalent to 0.32 ± 0.02 IU/mg of support. After
immobilization, the remaining activity in the supernatant
was 14 ± 0.01 IU/ml, equivalent to 0.092 ± 0.01 IU/mg
of support. The difference between them was expressed as
theoretical activity. The activity of immobilized antiacanthain
in glyoxyl-silica was 0.15 ± 0.01 IU/mg of support, and Ya
was 47 ± 0.01%. The offered activity of granulosain was 50
IU/ml, equivalent to 0.33 ± 0.02 IU/mg of support. After
immobilization, the remaining activity in the supernatant
was 20.7 ± 0.01 IU/ml, equivalent to 0.138 ± 0.01 IU/mg
of support. The activity of immobilized granulosain in
glyoxyl-silica was 0.093 ± 0.01 IU/mg of support, and
Ya was 28.18± 0.01%.
A higher Ya was obtained for antiacanthain under the
studied conditions. However, both enzymes showed 2.1–
3.5 times lower expressed activity than the offered activity.
It is likely that during the immobilization process the
Lys groups of the microenvironment of the active site
have bound to the support, hampering or decreasing
TABLE 1 | Catalytic potential of soluble antiacanthain (0.075 mg/ml, 1.875 IU/ml)
after 6 h in liquid-liquid biphasic systems constituted by several concentrations of
organic solvent in 100mM Tris(hydroxymethyl)amino methane hydrochloride buffer
pH 8, at 40◦C.
Organic solvent Catalytic potential (IU/mg · h)*
30% 50% 70%
Benzene 140.70 ± 0.01h 125.33 ± 0.19f 121.75 ± 0.05g
Octanol 114.19 ± 0.25e 108.03 ± 0.05c 78.33 ± 0.01b
Dichloromethane 123.64 ± 0.01f 116.77 ± 0.05d 104.39 ± 0.10d
Diethyl ether 97.68 ± 0.05c 93.07 ± 0.09b 116.71 ± 0.34e
Cyclohexane 134.71 ± 0.05g 147.19 ± 0.01g 120.82 ± 0.05f
Chlorobenzene 68.76 ± 0.23a 123.57 ± 0.01e 56.50 ± 0.02a
Acetophenone 85.57 ± 0.01b 89.22 ± 0.01a 83.24 ± 0.01c
Ethyl ethanoate 104.97 ± 0.15d 170.62 ± 0.01h 126.40 ± 0.01h
The catalytic potential of antiacanthain in 100mM Tris(hydroxymethyl)amino methane
hydrochloride buffer pH 8, at 40◦C was 116.48 ± 0.01 (IU/mg · h).
*Catalytic potential data are expressed as the mean ± SD (standard deviation) of
three independent experiments which were done in duplicate. The values with different
superscript letters in a column are significantly different (p < 0.05) (IBM SPSS
Statistics 27.0).
the specific activity of antiacanthain and granulosain at
pH 10 (30–33).
Catalytic Potential of Soluble and
Immobilized Antiacanthain and
Granulosain
Antiacanthain and granulosain catalytic potentials were studied
under non-reactive conditions, at 40◦C under agitation at 220
rpm, in several systems: 100mM Tris(hydroxymethyl)amino
methane hydrochloride buffer pH 8, liquid-liquid biphasic
systems (30, 50, and 70% v/v organic solvent in the same buffer),
and almost anhydrous organic solvents (Xw: 1× 10−5).
The proteolytic activity and the operational stability of soluble
and glyoxyl-silica immobilized enzymes were evaluated using the
catalytic potential as criteria (Equation 1) in order to select the
most robust catalyst and the most promissory medium for the
synthesis of Z-Tyr-Val-OH.
As shown in Table 1, soluble antiacanthain in half of the 24
different aqueous-organic biphasic media studied showed higher
catalytic potential than in 100mM Tris(hydroxymethyl)amino
methane hydrochloride buffer pH 8. The high stability shown
by antiacanthain is because the enzyme is dissolved in the
aqueous phase in the immiscible liquid-liquid systems, and
it does not come into contact with the organic solvent
(40, 53). Besides, the catalytic potential of antiacanthain was
independent of the organic solvent concentration, indicating that
the concentration did not alter the protein-water interactions
in the enzyme’s surrounding microenvironment and maintained
its active structure. This behavior, named molecular toxicity, is
well-known for other proteolytic enzymes (45, 54).
Unlike antiacanthain, soluble granulosain showed lower
catalytic potential in all liquid-liquid biphasic media than
in 100mM Tris(hydroxymethyl)amino methane hydrochloride
buffer pH 8 (Table 2). The partitioned organic solvent into
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TABLE 2 | Catalytic potential of soluble granulosain (0.125 mg/ml, 1.850 IU/ml)
after 6 h in liquid-liquid biphasic systems constituted by several concentrations of
organic solvent in 100mM Tris(hydroxymethyl)amino methane hydrochloride buffer
pH 8, at 40◦C.
Organic solvent Catalytic potential (IU/mg · h)*
30% 50% 70%
Benzene 76.38 ± 0.15a 139.42 ± 0.00d 56.09 ± 0.24d
Octanol 13.05 ± 0.09e 17.92 ± 0.01a 0 ± 0.00a
Dichloromethane 121.57 ± 0.01h 191.09 ± 0.01g 29.98 ± 0.33c
Diethyl ether 38.53 ± 0.00c 25.47 ± 0.05b 0 ± 0.00a
Cyclohexane 92.31 ± 0.28f 176.92 ± 0.03e 57.90 ± 0.25e
Chlorobenzene 73.18 ± 0.01d 188.01 ± 0.01f 61.15 ± 0.01f
Acetophenone 16.45 ± 0.05b 64.77 ± 0.20c 0 ± 0.00a
Ethyl ethanoate 117.56 ± 0.01g 200.14 ± 0.01h 4.42 ± 0.00b
The catalytic potential of granulosain in 100mM Tris(hydroxymethyl)amino methane
hydrochloride buffer pH 8, at 40◦C was 350 ± 0.01 (IU/mg · h).
*Catalytic potential data are expressed as the mean ± SD (standard deviation) of
three independent experiments which were done in duplicate. The values with different
superscript letters in a column are significantly different (p < 0.05) (IBM SPSS
Statistics 27.0).
aqueous phase affected the catalytic expression of granulosain,
as a consequence of the changes that the secondary structure
of granulosain underwent in those media (55). Besides, the
increased interface when using organic solvent at 70% (v/v) in
the biphasic systems seems to be the cause of the decrease or loss
of enzyme activity. This behavior has been named phase toxicity
in the literature (56).
However, 50% v/v ethyl ethanoate in 100mM
Tris(hydroxymethyl)aminomethane hydrochloride buffer
pH 8.0 allowed to express the highest catalytic potential of both
soluble peptidases (antiacanthain and granulosain). For this
reason, this liquid-liquid biphasic medium was selected for
the synthesis of Z-Tyr-Val-OH, using soluble and immobilized
enzymes. Glyoxyl-silica immobilized peptidases showed
significant lower catalytic potential than soluble peptidases in
that biphasic medium.
Furthermore, almost anhydrous organic solvents were
prepared with the addition of a certain water concentration
in order to obtain a constant relative fraction of water
(Xw) in the enzymes of 1 × 10−5. A constant relative
fraction of water higher than 1 × 10−5 led to the formation
of biphasic systems when some of the organic solvents
were used.
Soluble and glyoxyl-silica immobilized granulosain
were completely inactivated in almost anhydrous organic
solvents. Under these conditions, the soluble and immobilized
antiacanthain showed low activity, but after 6 h in ethyl
ethanoate (Xw: 1 × 10−5) they were able to retain 17.3
and 45% of the initial specific activity in 100mM Tris
hydrochloride buffer pH 8.0 at 40◦C under agitation (200
rpm), respectively (Figure 2). For this reason, ethyl ethanoate
(Xw: 1 × 10−5) was selected as the almost anhydrous organic
medium for the synthesis of Z-Tyr-Val-OH, using soluble and
immobilized antiacanthain.
FIGURE 2 | Comparative residual activity (%) of soluble antiacanthain (0.075
mg/ml, 1.875 IU/ml) in 100mM Tris(hydroxymethyl)amino methane
hydrochloride buffer pH 8 vs. soluble antiacanthain (0.075 mg/ml) in almost
anhydrous organic solvents (Xw: 1 × 10
−5) and glyxoyl-silica immobilized
antiacanthain (12.5 mg/ml) in almost anhydrous ethyl ethanoate (Xw: 1 ×
10−5), after 6 h of incubation at 40◦C under agitation at 200 rpm. (1) Control
(Tris buffer pH 8, initial specific activity: 100%); (2) Tris buffer pH 8; (3) Diethyl
ether; (4) Chlorobenzene; (5) Acetophenone; (6) Octanol; (7) Benzene; (8)
Dichloromethane; (9) Cyclohexane; (10) Ethyl ethanoate (soluble
antiacanthain); (11) Ethyl ethanoate (glyoxyl-silica immobilized antiacanthain).
Antiacanthain and Granulosain
Preferences
The amino acid side chain parameters play an important role
in the specificity of the enzyme because they are responsible
for the hydrophobic, steric, and electronic interactions in the
surroundings of the active site (43).
Table 3 shows the specificity of antiacanthain and granulosain
using different synthetic amino acid substrates in 50% v/v
ethyl ethanoate in 100mM Tris (hydroxymethyl)aminomethane
hydrochloride buffer pH 8.0, at 40◦C. Antiacanthain showed high
preference for polar substrates, such as the synthetic derivatives
of Asn, Tyr, Gln, and Val. Granulosain in 50% v/v ethyl ethanoate
in 100mM Tris(hydroxymethyl)aminomethane hydrochloride
buffer pH 8.0 showed high preferences for Tyr, Val, Ile, and Asp.
In peptide synthesis by protease-mediated reactions, the acyl
donor binds to the S subsite of the enzyme and the amino
component that acts as an acyl acceptor interacts with the S’
binding site (57). The reaction rate will depend on the acyl donor
specificity by the protease. The efficiency of the nucleophilic
attack of the added amino component depends on an optimal
binding in the region of the S’ subsite of the protease, being
crucial for obtaining a high peptide yield.
Antiacanthain and granulosain showed high preference for
the Tyr derivative, using p-nitrophenyl esters of N-protected
amino acids as substrates, suggesting that Z-Tyr-pNO would be
a suitable acyl donor substrate for the synthesis reaction. Then,
Z-Tyr-pNO and Val-OH were chosen as acyl donor and acyl
acceptor, respectively, for the synthesis of Z-Tyr-Val-OH.
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TABLE 3 | Preferences of the partially purified enzymatic extracts: soluble antiacanthain (0.075 mg/ml, 1.875 IU/ml) and soluble granulosain (0.125 mg/ml, 1.850 IU/ml),





UCBZ Preference (%) UCBZ Preference (%)
Tyr 47.95 ± 0.05j 90.6 2.20 ± 0.147c 100
Asn 52.91 ± 0.07k 100 1.90 ± 0.121bc 86.4
Gln 41.40 ± 0.40i 78.2 1.60 ± 0.170b 72.7
Gly 35.08 ± 0.42g 66.3 1.60 ± 0.103b 72.7
Lys 31.9 ± 0.085f 60.3 0.00 ± 0.00a 0
Phe 0.00 ± 0.00a 0 1.00 ± 0.125d 45.5
Trp 5.94 ± 0.06b 11.2 0.30 ± 0.147a 13.6
Val 35.77 ± 0.22h 67.6 2.10 ± 0.193c 95.5
Ile 12.87 ± 0.12e 24.3 2.00 ± 0.147bc 90.9
Leu 8.86 ± 0.14c 16.7 0.00 ± 0.00a 0
Ala 11.95 ± 0.05d 22.6 0.00 ± 0.00a 0
The values with different superscript letters in a column are significantly different (p < 0.05) (IBM SPSS Statistics 27.0).
Enzymatic Synthesis of Peptide
The kinetically-controlled synthesis of Z-Tyr-Val-OHwas carried
out with Z-Tyr-pNO and Val-OH as acyl donor and acyl
acceptor, respectively, in two different reaction media formed by
50% v/v ethyl ethanoate in 100mM Tris(hydroxymethyl)amino
methane hydrochloride buffer pH 8.0, and almost anhydrous
ethyl ethanoate (Xw: 1 × 10−5 in the enzymes into the organic
solvent). Those media allowed a high solubility of the substrates,
which were 75.5mM for Val-OH in water and 189mM for Z-Tyr-
pNO in ethyl ethanoate, an acyl donor partition coefficient of 1.28
and the best catalytic potential of both enzymes (Tables 1, 2).
Figures 3A,B shows the separation of components by RP-
HPLC of two representative samples of the enzymatic synthesis
of Z-Tyr-Val-OH, using antiacanthain and granulosain as soluble
biocatalysts, after 4 h and 30min of reaction, respectively.
According to Figures 3A,B, at a retention time (tR) of 5.27min,
a peak of the main product (Z-Tyr-Val-OH) was observed in
the organic phase. The product was easily separated from the
organic layer after pausing the orbital shaker, and the synthetized
peptide was purified (>95% purity) by chromatography, using a
SPE-Cartridge C18. Figure 4 shows the mass spectrum of Z-Tyr-
Val-OH, m/z: 414.32.
Figures 5A,B shows the time-course of the reactions of
synthesis of Z-Tyr-Val-OH, using antiacanthain and granulosain
as soluble biocatalysts, respectively.
The only condensation product is converted into hydrolysis
product (Z-Tyr-OH) after 30min of reaction using granulosain
as soluble biocatalysts. This effect was not observed when
antiacanthain was used as biocatalyst and a maximum peptide
concentration was obtained after 4 h without further hydrolysis.
However, in both cases, the hydrolysis product (Z-Tyr-OH) was
obtained from the acyl-donor substrate (Z-Tyr-pNO). It is well-
known that, in the coupling reaction under kinetic control, the
activated acyl donor becomes an intermediate, the so-called acyl-
enzyme form, which reacts with the nucleophile for making
the C-terminal segment of the peptide product. In a liquid-
liquid biphasic system, the coupling reaction is carried out in
FIGURE 3 | Component separation by RP-HPLC of a representative sample
from Z-Tyr-Val-OH enzymatic synthesis under kinetic control, using: (A)
antiacanthain (0.075 mg/ml, 1.875 IU/ml) and (B) granulosain (0.125 mg/ml,
1.875 IU/ml) as soluble biocatalysts, in 50% v/v ethyl ethanoate and 100mM
Tris(hydroxymethyl)amino methane hydrochloride buffer pH 8, after 4 h and
30min of reaction, respectively; at 40◦C under agitation at 200 rpm. I:
antiacanthain (tR: 3–4.4min) and granulosain (tR: 2,7–3,2min); II: Z-Tyr-Val-OH
(tR: 5.27min); III: Z-Tyr-pNO (tR: 14.5min). Aqueous phase: blue line. Organic
phase: pink line.
the aqueous phase, where water can cleave the acyl-enzyme
intermediate to give the hydrolyzed substrate (27). In fact, the
hydrolysis of the acyl donor substrate decreased the product
yields in the synthesis reaction of Z-Tyr-Val-OH, with either
antiacanthain or granulosain as soluble biocatalysts.
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FIGURE 4 | Mass spectrum of the carboxy terminal peptide Z-Tyr-Val-OH,
m/z: 414.32.
FIGURE 5 | Time-course of the kinetically-controlled synthesis of Z-Tyr-Val-OH
in 50% v/v ethyl ethanoate and 100mM Tris(hydroxymethyl)amino methane
hydrochloride buffer pH 8, at 40◦C under agitation at 200 rpm; using: (A)
antiacanthain (0.075 mg/ml, 1.875 IU/ml) and (B) granulosain (0.125 mg/ml,
1.850 IU/ml) as soluble biocatalysts.
Table 4 shows Z-Tyr-Val-OH product yields (η) of the
enzymatic synthesis under kinetic control, using 50% v/v
ethyl ethanoate in 100mM Tris(hydroxymethyl)amino methane
hydrochloride buffer pH 8 as reaction medium and soluble
peptidases (antiacanthain and granulosain) as biocatalysts.
Soluble antiacanthain showed a slightly higher peptide yield
than soluble granulosain, under those conditions. However,
soluble granulosain showed higher peptide productivity (14.6 ±
0.01 mM/h) than soluble antiacanthain (2.30 ± 0.015 mM/h),
but 58% of the substrate was rapidly hydrolyzed to Z-Tyr-OH
preventing the synthesis could continue.
It is noteworthy that equimolecular substrate concentrations
in the aqueous phase of the liquid-liquid biphasic media were
used in those trials. Consequently, two strategies were applied to
maximize η: (1) the acyl acceptor concentration was increased
until its maximum solubility (75.5mM); and (2) Immobilized
enzymes (antiacanthain and granulosain) by multi-point
covalent bonding in glyoxyl-silica were applied as biocatalysts of
the peptide synthesis reaction in both selected media: 50% v/v
ethyl ethanoate in 100mM Tris(hydroxymethyl)amino methane
hydrochloride buffer pH 8 and almost anhydrous ethyl ethanoate
(Xw: 1× 10−5).
Under the first strategy, at acyl acceptor/donor molar ratio
of 10, the peptide yields were 72 ± 0.15 and 60 ± 0.10% using
soluble antiacanthain and granulosain, respectively (Table 5).
These values were 35 and 15% higher than those obtained
under equimolar concentrations of both reactants, using 50% v/v
ethyl ethanoate in 100mM Tris hydrochloride buffer pH 8.0 as
reaction medium (Table 4). The maximum peptide productivity
(20.7 ± 0.015 mM/h) was obtained using soluble granulosain as
biocatalyst in the same reaction medium.
The synthesis of Z-Tyr-Val-OH did not work in almost
anhydrous ethyl ethanoate (Xw: 1 × 10−5), under the
same reaction conditions, because the soluble peptidases
(antiacanthain and granulosain) were quickly inactivated.
Under the second strategy, the multi-point immobilization
of antiacanthain and granulosain in glyoxyl-silica did not lead
to better peptide yields than soluble enzymes, using the liquid-
liquid biphasic medium formed by 50% v/v ethyl ethanoate
in 100mM Tris(hydroxymethyl)amino methane hydrochloride
buffer pH 8. However, immobilized antiacanthain prove to be a
robust biocatalyst in almost anhydrous ethyl ethanoate (Xw: 1 ×
10−5), eliciting amaximumpeptide yield of 75± 0.13% (Table 6).
Immobilized granulosain was inactivated in almost anhydrous
ethyl ethanoate, under the same reaction conditions.
Table 6 shows that the acyl-donor ester was neither
completely consumed nor hydrolyzed after 6 h. This fact
was due to the faster deactivation of antiacanthain-glyoxyl-silica
in the almost anhydrous organic solvent than in the liquid-liquid
biphasic system. The direct effect of the organic solvent on
the enzyme could be the main reason of deactivation. The
literature reports that other enzymes in almost anhydrous
organic solvents showed an increased structural rigidity which
led to a lower reactivity (27, 34). The substrate solvation (into the
microenvironment of the enzyme active site) does not seem to
be the deactivation cause because as the reaction progresses the
amount of water produced also increases. Besides, internal mass
transfer limitations of the substrate (due to a higher reaction
rate than the substrate diffusion rate) have not been observed
when glyoxyl silica immobilized antiacanthain was placed in
almost anhydrous ethyl ethanoate (Xw: 1 × 10−5). In effect,
the peptide productivity in this system was 2.16 ± 0.01 mM/h,
a value close to that obtained in 50% v/v ethyl ethanoate in
100mM Tris(hydroxymethyl)amino methane hydrochloride
buffer pH 8.
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TABLE 4 | Yields (η) obtained in the kinetically controlled synthesis of Z-Tyr-Val-OH, using 50% v/v ethyl ethanoate in 100mM Tris(hydroxymethyl)amino methane
hydrochloride buffer pH 8 as medium, and antiacanthain (0.075 mg/ml, 1.875 IU/ml) and granulosain (0.125 mg/ml, 1.850 IU/ml) as soluble biocatalysts, at 40◦C under
agitation at 200 rpm.
Time (min) Z-Tyr-Val-OH (mM) αs (%) η (%)
Antiacanthain Granulosain Antiacanthain Granulosain Antiacanthain Granulosain
0 0b 0b 0a 0a 0a 0a
1 0.35 ± 0.03c 4.16 ± 0.05e 4.6 ± 0.09b 31.4 ± 0.05b 2.45 ± 0.09b 29.7 ± 0.03f
5 1.75 ± 0.20d 5.22 ± 0.10f 23.2 ± 0.33c 51.4 ± 0.10c 10.1 ± 0.10c 37.3 ± 0.07g
15 2.20 ± 0.01e 6.80 ± 0.05g 29.4 ± 0.19d 60.0 ± 0.25d 12.75 ± 0.05d 48.6 ± 0.03h
30 4.30 ± 0.01f 7.30 ± 0.10h 41.3 ± 0.12e 67.6 ± 0.09e 24.93 ± 0.12e 52.1 ± 0.10i
60 7.53 ± 0.10g 3.50 ± 0.09d 63.1 ± 0.20f 80.6 ± 0.45f 43.65 ± 0.09f 25.0 ± 0.15e
150 8.53 ± 0.05h 3.00 ± 0.10c 76.9 ± 0.07g 84.6 ± 0.52g 49.45 ± 0.05g 21.4 ± 0.09d
240 9.22 ± 0.01a 2.35 ± 0.01a 91.3 ± 0.05h 88.1 ± 0.09h 53.45 ± 0.01h 16.8 ± 0.05c
360 9.02 ± 0.12a 2.10 ± 0.20a 100 ± 0.01i 100 ± 0.01i 52.28 ± 0.05i 15.0 ± 0.10b
Acyl acceptor/donor molar ratio: 1. αs is the conversion percentage of acyl donor substrate.
The values with different superscript letters in a column are significantly different (p < 0.05) (IBM SPSS Statistics 27.0).
Bold values represent the maximal peptide yields from each experimental trial set.
TABLE 5 | Yields (η) obtained in the kinetically controlled synthesis of Z-Tyr-Val-OH, using 50% v/v ethyl ethanoate in 100mM Tris(hydroxymethyl)amino methane
hydrochloride buffer pH 8 as medium, and antiacanthain (0.075 mg/ml, 1.875 IU/ml) and granulosain (0.125 mg/ml, 1.850 IU/ml) as soluble biocatalysts, at 40◦C under
agitation at 200 rpm.
Time (min) Z-Tyr-Val-OH (mm) αs (%) η (%)
Antiacanthain Granulosain Antiacanthain Granulosain Antiacanthain Granulosain
0 0b 0a 0a 0b 0a 0a
1 0.57 ± 0.32c 2.45 ± 0.02b 3.77 ± 0.10b 14.2 ± 0.05c 3.29 ± 0.0b 14.2 ± 0.00b
5 1.83 ± 0.01d 6.16 ± 0.23f 10.6 ± 0.32c 35.7 ± 0.01d 10.6 ± 0.05c 35.7 ± 0.01f
15 4.23 ± 0.05e 8.16 ± 0.03h 24.5 ± 0.01d 52.7 ± 0.35e 24.5 ± 0.10d 47.3 ± 0.05h
30 6.21 ± 0.05f 10.3 ± 0.05i 36.0 ± 0.14e 76.3 ± 0.05f 36.0 ± 0.02e 60.0 ± 0.05i
60 10.2 ± 0.01g 7.33 ± 0.05g 73.3 ± 0.05f 81.2 ± 0.51g 59.3 ± 0.01f 42.5 ± 0.03g
150 11.9 ± 0.07h 5.71 ± 0.21e 89.6 ± 0.45g 93.5 ± 0.03h 68.7 ± 0.05g 33.1 ± 0.20e
240 12.4 ± 0.01a 4.23 ± 0.05d 98.0 ± 0.05h 100 ± 0.00a 72.0 ± 0.01h 24.5 ± 0.05d
360 12.2 ± 0.25a 3.67 ± 0.05c 100 ± 0.00i 100 ± 0.00a 70.8 ± 0.05i 21.0 ± 0.20c
Acyl acceptor/donor molar ratio: 10. αs is the conversion percentage of acyl donor substrate.
The values with different superscript letters in a column are significantly different (p < 0.05) (IBM SPSS Statistics 27.0).
Bold values represent the maximal peptide yields from each experimental trial set.
Finally, under thermodynamic control, both soluble and
immobilized peptidases (antiacanthain and granulosain) did
not catalyze the synthesis of Z-Tyr-Val-OH peptide in 50%
v/v ethyl ethanoate in 100mM Tris(hydroxymethyl)amino
methane hydrochloride buffer pH 8 and in almost anhydrous
ethyl ethanoate, despite of the high selectivity showed by
both enzymes under kinetic control in those media, where
no by-products were formed. This fact showed that these
enzymes do not work against not activated acyl donors,
such as Z-Tyr-OH.
Antibacterial Activity of Z-Tyr-Val-OH
Antibacterial activity of Z-Tyr-Val-OH was tested through three
independent trials, in duplicate, against S. aureus ATCC 25923
and E. coli ATCC 25922 as reference strains in batch culture
with Müller-Hinton broth at 37◦C under agitation at 180 rpm,
using increasing concentrations of Z-Tyr-Val-OH (0–50µg/ml)
(Figure 6).
According to the Kruskal-Wallis method, the Z-Tyr-Val-
OH peptide at all concentrations tested produced a significant
decrease (p ≤ 0.05) in specific growth rates (mean values) of
S. aureus with respect to the control (Table 7). Besides, Z-Tyr-
Val-OH showed a significant decrease (p ≤ 0.05) in the specific
growth rates of E. coli, with respect to the control, at≥ 35 µg/ml.
Table 8 shows the minimum inhibitory concentrations
(MICs) values of Z-Tyr-Val-OH against the reference strains (S.
aureus and E. coli) and six wild strains isolated in the Central
Microbiology Laboratory of the San Luis Ministry of Health,
Government of San Luis, Province of San Luis, Argentina.
MICs of Z-Tyr-Val-OH against the reference strains, S. aureus
and E. coli, were 47.5 ± 0.01 and 55 ± 0.01µg/ml, respectively.
Those MICs values were higher than those reported by oxacillin
(31.1µg/ml) or nalidixic acid (21.7µg/ml) under similar culture
conditions (46, 47).
All Gram positive and Gram negative wild strains sensitive
to commonly used antibiotics, such as Staphylococcus aureus
Frontiers in Nutrition | www.frontiersin.org 11 June 2021 | Volume 8 | Article 685330
Adaro et al. Novel Antibacterial Dipeptide as Food-Preservative
TABLE 6 | Yields (η) obtained in the kinetically controlled synthesis of Z-Tyr-Val-OH in ethyl ethanoate (Xw: 1 × 10
−5 in the enzyme into the organic solvent) at 40◦C, using
glyoxyl-silica immobilized antiacanthain (12.5 mg/ml) as biocatalyst.
Time (min) Z- Tyr-pNO (mM) Z-Tyr-Val-OH (mM) αs (%) η (%)
0 17.25 0 0a 0a
5 14.83 2.41 14 ± 0.20b 14 ± 0.00b
15 12.94 4.30 25 ± 0.37c 25 ± 0.01c
30 10.35 6.90 40 ± 0.00d 40 ± 0.15d
60 9.15 8.20 47 ± 0.10e 47± 0.03e
240 4.80 12.10 72 ± 0.00f 70 ± 0.02f
360 4.25 12.94 75 ± 0.18g 75 ± 0.13g
αs is the conversion percentage of acyl donor substrate.
The values with different superscript letters in a column are significantly different (p < 0.05) (IBM SPSS Statistics 27.0).
Bold values represent the maximal peptide yields from each experimental trial set.
FIGURE 6 | Growth kinetics of (A) Staphylococcus aureus ATCC 25923 and
(B) Escherichia coli ATCC 25922 in batch cultures, at 37◦C under agitation at
180 rpm, using Müller-Hinton broth and several Z-Tyr-Val-OH concentrations
within the range from 0 to 50 µg/ml.
C00195, Staphylococcus hominisA17771 and E. coliA17683, were
also susceptible to Z-Tyr-Val-OH. MICs values of these wild
strains sensitive to commonly used antibiotics ranged from 96.0
± 0.00 to 123.0± 0.10µg/ml. Besides, Klebsiella oxytocaA19438,
TABLE 7 | Statistical analysis by the Kruskal – Wallis test of the specific growth
rate in batch culture of Staphylococcus aureus ATCC 25923 and Escherichia coli
ATCC 25922, using Müller-Hinton broth and the addition of different
concentrations of Z-Tyr-Val-OH, at 37◦C under agitation at 180 rpm.
Z-Tyr-Val-OH (µg/ml) Kruskal-Wallis test (p) Specific growth rate (h−1)
Staphylococcus aureus ATCC 25923
0 – 4.26 ± 0.11
15 0.050 1.62 ± 0.15
25 0.001 1.25 ± 0.20
35 0.000 1.02 ± 0.18
50 0.000 1.00 ± 0.17
Escherichia coli ATCC 25922
0 – 3.68 ± 0.17
15 0.100 3.15 ± 0.19
25 0.600 2.47 ± 0.15
35 0.023 1.74 ± 0.20
50 0.004 1.14 ± 0.015
a Gram negative wild strain with natural or intrinsic resistance
to ampicillin, was also susceptible to Z-Tyr-Val-OH at≥ 140.0±
0.05 µg/ml.
Conversely, Z-Tyr-Val-OH was not effective within the ranges
tested against bacteria with single resistance to carbapenems and
withmultiple resistances to vancomycin and β-lactam antibiotics,
such as Pseudomonas aeruginosa C00213 and Enterococcus
faecalis I00125, respectively. It is essential to highlight that the
Z-Tyr-Val-OH sequence has not yet been reported in bioactive
peptide databases, such as: PepBank (58), PeptideDB (59),
BIOPEP (60); nor in the databases of antimicrobial peptides, such
as: APD3, Antimicrobial Peptide Database (61), and CAMP (62).
CONCLUSIONS
This work reports two partially purified proteolytic extracts from
the fruits of Bromelia antiacantha and Solanum granulosum
leprosum, belonging to the papain-like family of peptidases, as
new biocatalysts for the green synthesis of bioactive peptides.
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TABLE 8 | MICs of Z-Tyr-Val-OH peptide determined for Gram positive and Gram negative strains.
Microorganism MICs*
Z-Tyr-Val-OH (µg/ml) Oxacillin (µg/ml) Nalidixic acid (µg/ml)
Gram positive bacteria
Staphylococcus aureus ATCC 25923 47.5 ± 0.01b 31.1 (47)
Staphylococcus aureus C00195 96.0 ± 0.00a
Staphylococcus hominis A17771 96.0 ± 0.05a
Enterococcus faecalis I00125 (MDR) —
Gram negative bacteria
Escherichia coli ATCC 25922 55.0 ± 0.01a 21.7 (48)
Escherichia coli A17683 123.0 ± 0.10b
Klebsiella oxytoca A19438 (SDR) 140.0 ± 0.05c
Pseudomonas aeruginosa C00213 (SDR) —
*MICs data are representative of three independent experiments which were done in duplicate. MDR, multidrug resistance; SDR, single-drug resistance. The values with different
superscript letters in a column are significantly different (p<0.05) (IBM SPSS Statistics 27.0).
Despite their similar nature, antiacanthain showed different
behavior than granulosain for the production of the novel
antibacterial dipeptide Z-Tyr-Val-OH. Soluble antiacanthain
catalyzed the dipeptide synthesis under kinetic-control with
high yield (72%) in 50% v/v ethyl ethanoate in 100mM
Tris(hydroxymethyl)amino methane hydrochloride buffer pH 8,
while glyoxyl-silica immobilized antiacanthain allow to obtain
the best peptide yield (75%) in almost anhydrous ethyl ethanoate
(Xw: 1 × 10−5). Soluble granulosain showed slightly lower
peptide yields and higher peptide productivities than soluble
antiacanthain in that liquid-liquid biphasic medium, but soluble
and immobilized granulosain were inactivated in the almost
anhydrous ethyl ethanoate (Xw: 1 × 10−5). Both enzymes were
highly selective for the synthesis of Z-Tyr-Val-OH, and no other
products were synthesized.
Glyoxyl-silica immobilized antiacanthain showed a much
better performance than the soluble enzyme in almost anhydrous
organic solvents. However, other immobilization methodologies
need to be investigated to decrease the enzyme’s inactivation
rates under those hard reaction conditions, for leading to more
sustainable production processes.
Nowadays, the molecular effect of organic solvents on the
activity and stability of antiacanthain and granulosain, and
changes related to solvation, flexibility and secondary structure of
those enzymes in different aqueous-organic biphasic media and
in almost anhydrous organic solvents are being evaluated.
This work reports a novel broad-spectrum antibacterial
peptide (Z-Tyr-Val-OH) that significantly decreased (p ≤ 0.05)
the specific growth rates of Gram positive and Gram negative
reference bacteria at very low concentrations of ≥15 and
35µg/ml, respectively.
Z-Tyr-Val-OH also showed high efficacy at low concentrations
against Gram positive and Gram negative wild strains sensitive to
conventional antibiotics. Furthermore, the novel dipeptide was
very effective at ≥140.0 ± 0.05µg/ml against Gram negative
wild bacteria with single resistance to ampicillin, such as K.
oxytoca. This last antimicrobial activity of Z-Tyr-Val-OH gives
relevance and novelty to this work because K. oxytoca is an
emergingmulti-drug resistant bacterium in the hospital-acquired
infections by adults.
Conversely, the dipeptide did not demonstrated efficacy
against bacteria with single resistance to carbapenems and with
multiple resistances to vancomycin and β-lactam antibiotics,
within the range tested.
Finally, this study contributes with a new efficient and safe
food preservative to be applied to different real food systems.
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